Published in Semin Nucl Med on April 01, 1995
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
The role of nuclear medicine in clinical investigation. BMJ (1998) 0.81
Dyslexia: cultural diversity and biological unity. Science (2001) 4.17
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
Localization of grasp representations in humans by PET: 1. Observation versus execution. Exp Brain Res (1996) 2.80
Brain activity during observation of actions. Influence of action content and subject's strategy. Brain (1997) 2.73
A cultural effect on brain function. Nat Neurosci (2000) 2.69
Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging (2004) 2.41
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
[Rapid increase of the use of PET in cancer investigation--but Sweden lags behind]. Lakartidningen (2000) 2.02
Economics of myocardial perfusion imaging in Europe--the EMPIRE Study. Eur Heart J (1999) 2.01
Mapping motor representations with positron emission tomography. Nature (1994) 2.00
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol (1998) 1.92
The bilingual brain. Proficiency and age of acquisition of the second language. Brain (1998) 1.75
The neural correlates of verb and noun processing. A PET study. Brain (1999) 1.71
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus (1999) 1.70
Assessment of regional ventilation by continuous inhalation of radioactive krypton-81m. Br Med J (1975) 1.62
Clinical role of positron emission tomography in oncology. Lancet Oncol (2001) 1.62
Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58
Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. Am J Psychiatry (1997) 1.58
A training simulator for sentinel node biopsy in breast cancer: a new standard. Eur J Surg Oncol (2005) 1.57
Brain abnormalities underlying altered activation in dyslexia: a voxel based morphometry study. Brain (2005) 1.55
Sentinel lymph node detection and imaging. Eur J Nucl Med (1999) 1.52
Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy. Scand J Rheumatol (1996) 1.50
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry (2006) 1.49
Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage (1999) 1.47
High prevalence of the thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur Heart J (1996) 1.47
Emission and transmission brain tomography. Br Med J (1980) 1.46
99mTc-HMPAO washout in prognosis of stroke. Lancet (1989) 1.46
Inter-observer agreement in the reporting of 99Tcm-DMSA renal studies. Nucl Med Commun (1996) 1.45
Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord (1995) 1.43
Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease): a case report. Brain Dev (1995) 1.42
Aphasia and neglect after subcortical stroke. A clinical/cerebral perfusion correlation study. Brain (1987) 1.41
Striatal dopamine receptor binding in epileptic psychoses. Biol Psychiatry (1994) 1.41
Influence of arm positioning on tomographic thallium-201 myocardial perfusion imaging and the effect of attenuation correction. Eur J Nucl Med (2000) 1.40
PET reflections. Eur J Nucl Med (1990) 1.39
Role of radionuclide venography in the detection of proximal deep vein thrombosis: a prospective comparative study. Nucl Med Commun (1993) 1.39
Keeping abreast of time. Eur J Nucl Med (1995) 1.39
Postviral fatigue syndrome. BMJ (1992) 1.39
Brain processing of native and foreign languages. Neuroreport (1996) 1.38
Recovery from aphasia and neglect after subcortical stroke: neuropsychological and cerebral perfusion study. J Neurol Neurosurg Psychiatry (1988) 1.37
Interhemispheric transmission of visuomotor information in humans: fMRI evidence. J Neurophysiol (2002) 1.33
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord (2003) 1.33
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol (2003) 1.32
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain (2001) 1.32
Prosopagnosia can be associated with damage confined to the right hemisphere--an MRI and PET study and a review of the literature. Neuropsychologia (1994) 1.31
Word and picture matching: a PET study of semantic category effects. Neuropsychologia (1999) 1.29
Syntax and the brain: disentangling grammar by selective anomalies. Neuroimage (2001) 1.29
Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry (2002) 1.28
Different brain correlates for watching real and virtual hand actions. Neuroimage (2001) 1.28
A fMRI study of word retrieval in aphasia. Brain Lang (2003) 1.27
Regional reductions of gray matter volume in familial dyslexia. Neurology (2004) 1.25
Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer. Eur J Nucl Med Mol Imaging (2004) 1.24
[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry (1995) 1.23
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology (2008) 1.21
Acupuncture produces central activations in pain regions. Neuroimage (2001) 1.21
Phasic abnormalities of left ventricular emptying in coronary artery disease. Br Heart J (1981) 1.21
Cerebral consequences of cardiopulmonary bypass. Lancet (1986) 1.20
Left and right hemisphere contribution to recovery from neglect after right hemisphere damage--an [18F]FDG pet study of two cases. Neuropsychologia (1993) 1.20
A PET follow-up study of recovery after stroke in acute aphasics. Brain Lang (1997) 1.20
Crossed aphasia: a PET follow up study of two cases. J Neurol Neurosurg Psychiatry (1993) 1.19
Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol (1992) 1.18
How far investigations for occult metastases in breast cancer aid the clinician. Clin Oncol (R Coll Radiol) (1991) 1.17
Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation (1996) 1.16
Visual feedback has differential effects on reaching movements in Parkinson's and Alzheimer's disease. Brain Res (2000) 1.15
Quantitative measurement of regional extravascular lung density using positron emission and transmission tomography. J Comput Assist Tomogr (1981) 1.15
Functional heterogeneity of left inferior frontal cortex as revealed by fMRI. Neuroreport (1997) 1.15
Intrapancreatic accessory spleen mimicking a neuroendocrine tumor: magnetic resonance findings and possible diagnostic role of different nuclear medicine tests. Eur Radiol (2003) 1.14
Emission computerised tomography. A new diagnostic imaging technique. Lancet (1978) 1.14
The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry (1989) 1.12
Assessment of myocardial function before aortic surgery by radionuclide angiocardiography. Br J Surg (1985) 1.12
X-ray dual-photon absorptiometry: a new method for the measurement of bone density. Br J Radiol (1989) 1.12
Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study. Q J Med (1992) 1.11
Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis. J Nucl Med (1995) 1.10
Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.10
Different neural systems for the recognition of animals and man-made tools. Neuroreport (1995) 1.10
In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography. Gut (2003) 1.09
Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma. J Nucl Med (1996) 1.09
Diagnosing Alzheimer's disease. BMJ (1992) 1.08
Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study. Neuroimage (1996) 1.08
Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. Eur J Nucl Med Mol Imaging (2003) 1.07
Nonrefractory temporal lobe epilepsy: 1.5-T MR imaging. Radiology (1988) 1.06
81mKr ventilation and 99mTc perfusion scans in chest disease: comparison with standard radiographs. AJR Am J Roentgenol (1978) 1.05
A survey of radiation synovectomy in Europe, 1991-1993. Eur J Nucl Med (1995) 1.04
Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). Eur J Vasc Endovasc Surg (2009) 1.04
Regional cerebral metabolism of glucose in comatose and vegetative state patients. J Neurosurg Anesthesiol (1995) 1.04
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416. Eur J Nucl Med Mol Imaging (2004) 1.04
A functional-anatomical model for lipreading. J Neurophysiol (2003) 1.04
Impact of combined (18)F-FDG PET/CT in head and neck tumours. Br J Cancer (2005) 1.04